Navigation Links
MacAndrews & Forbes Names Barry F. Schwartz as Executive Vice Chairman
Date:10/11/2007

NEW YORK, Oct. 11 /PRNewswire/ -- MacAndrews & Forbes Holdings Inc. announced today the appointment of Barry F. Schwartz as Executive Vice Chairman and Chief Administrative Officer. As Chief Administrative Officer, Mr. Schwartz will supervise all legal, financial, governmental and administrative aspects of the Company's businesses. Mr. Schwartz will also continue, for some interim period, to serve as MacAndrews & Forbes's General Counsel.

"Barry has been an exemplary leader at MacAndrews & Forbes and I am delighted to have him work along side me in managing our operations and developing and implementing our strategic vision for growth. Barry, along with Howard and I, has been a member of an informal three person Executive Committee here for quite sometime, so this is a natural transition accelerated by the most unfortunate and sudden passing of our dear friend Howard", said Ronald O. Perelman, Chairman and Chief Executive Officer of MacAndrews & Forbes.

Mr. Schwartz joined MacAndrews & Forbes in 1989 and has been the Executive Vice President and General Counsel of the Company since 1993. He also serves as Acting Chief Executive Officer of M & F Worldwide Corp. and sits on the boards of Harland Clarke Holdings Corp., Revlon Consumer Products Corporation, Scientific Games Corporation, TransTech Pharma, Inc. and various other MacAndrews & Forbes companies.

Mr. Schwartz is a Member of the Board of Trustees of Kenyon College, serving on its Executive Committee, and is Chair of its Admissions and Financial Aid Committees. He also serves as a Trustee of the Association of Governing Boards of Universities and Colleges, and is a Member of the Board of Visitors of the Georgetown University Law Center.

About MacAndrews & Forbes Holdings Inc.

MacAndrews & Forbes is a private diversified holding company with interests in financial services, check printing and check related products and services, consumer products, gaming, entertainment, priva
'/>"/>

SOURCE MacAndrews & Forbes Holdings Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Forbes rating is more than kudos for Madison its a reflection on Wisconsin and the Midwest
2. Forbes Sr. Editor Kurt Bandenhausen on Forbes ranking of top cities for business
3. Forbes highlights Wisconsin biotech, names Madison #1 business city
4. Wisconsin IT association names Gee president, CEO
5. Quintessence Biosciences names new president
6. CDW names VP to handle Berbee merger
7. NimbleGen names CFO with capital-raising past
8. Cisco names Berbee a top partner of 2005
9. Cisco names Inacom most innovative partner
10. UW-Madison medical school names new dean
11. GE Healthcare names new CEO
Post Your Comments:
*Name:
*Comment:
*Email:
Other Biology Technology:PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting 2PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting 3PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting 4PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting 5PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting 6PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting 7Pearl Therapeutics Secures $8 Million in Debt Financing 2Pearl Therapeutics Secures $8 Million in Debt Financing 3Novartis/Schering-Plough's Drug Will Replace AstraZeneca's Symbicort as Decision Resources' Clinical Gold Standard by 2012 for the Treatment of Asthma 2
Breaking Biology News(10 mins):Study reveals how Arctic food webs affect mercury in polar bears 2Why King Kong failed to impress 2Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 2Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 3Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 4Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 5Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 6Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 7Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 8Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 9Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 10Discovery of the cells water gate may lead to new cancer drugs 8868 1Discovery of the cells water gate may lead to new cancer drugs 8868 2The Consumers Role in Medication Safety An Interactive Discussion with a Pharmacist on Live TV 49204 1The Consumers Role in Medication Safety An Interactive Discussion with a Pharmacist on Live TV 49204 2Help for Struggling CPAP Users Comes to Sleep HealthCenters in Weymouth 49201 1Help for Struggling CPAP Users Comes to Sleep HealthCenters in Weymouth 49201 2